Tech Company Financing Transactions

ArKal Medical Funding Round

Thomas, McNerny & Partners, Delphi Ventures and Medventure Associates participated in a $17.5 million Series B funding round for ArKal Medical. The round was announced on 9/16/2008.

Transaction Overview

Company Name
Announced On
9/16/2008
Transaction Type
Venture Equity
Amount
$17,500,000
Round
Series B
Investors

Thomas, McNerny & Partners (Lead Investor) (Peter McNerney)

Delphi Ventures (James Bochnowski)

Medventure Associates

Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
46575 Fremont Blvd.
Fremont, CA 94538
USA
Email Address
Overview
ArKal Medical is developing a novel continuous glucose monitoring system for the management of diabetes. ArKal's monitoring system is designed to eliminate many of the inconveniences of current glucose monitoring technologies.
Profile
ArKal Medical LinkedIn Company Profile
Social Media
ArKal Medical Company Twitter Account
Company News
ArKal Medical News
Facebook
ArKal Medical on Facebook
YouTube
ArKal Medical on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Arvind Jina
  Arvind Jina LinkedIn Profile  Arvind Jina Twitter Account  Arvind Jina News  Arvind Jina on Facebook


 

 

Browse more venture capital transactions:

Prev: 9/16/2008: Ounce Labs venture capital transaction
Next: 9/16/2008: Punchbowl Software venture capital transaction

 

Share this article

 


About Our Venture Capital Transactions Database

We do our best to document every notable VC transaction. All VC database entries reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary